NOVARTIS AG (NVSEF)
Clinical trial NCT05360446: enrollment: 610 → 608 participants.
Clinical trial NCT05360446: enrollment: 610 → 608 participants.
Clinical trial NCT07205484: completion date: 2030-07-01 → 2030-03-01.
Clinical trial NCT06681324 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 30 → 24 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT04269200 updates: 1. collaborators added: GOG Foundation, European Network of Gynaecological Oncological Trial Groups (ENGOT) 2. collaborators removed: The European Network for Gynaecological Oncological Trial groups (ENGOT), The Gynecologic Oncology Group (GOG) Foundation Inc
Clinical trial NCT05974579 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-03-31 → 2026-03-31 3. enrollment: 12 → 8 participants 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05369429 updates: 1. completion date: 2026-06-01 → 2028-07-05 2. primary completion date: 2026-06-01 → 2028-07-05
Clinical trial NCT07101081 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-01 → 2026-04-23
Clinical trial NCT07069309 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-05 → 2026-05-01 3. primary completion date: 2026-05-05 → 2026-05-01 4. enrollment: 760 → 774 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT03319901 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-04-30 → 2028-05-30 3. primary completion date: 2026-04-30 → 2025-11-25
Clinical trial NCT04750226 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-01 → 2026-04-27 3. primary completion date: 2026-04-01 → 2026-04-27